Biocon Biologics a subsidiary of Biocon announced today that it has entered into a definitive agreement with its partner Viatris Inc NASDAQ VTRS Accordingly Biocon Biologics BBL will acquire Viatris biosimilars business to create a unique fully integrated global biosimilars enterprise Viatris will receive consideration of up to USD 3335 billion including cash up to USD 2335 billion and Compulsorily Convertible Preference Shares CCPS in […]
Union Bank of India has considered the issuance of Basel III Compliant Debt Instruments in the nature of Debentures eligible for inclusion in Additional Tier-1 Capital Bonds Series XXXIV of Rs500 crore with Green Shoe Option up to Rs1000 crore maximum Rs1500 crore on Private Placement basis The deemed date of allotment is 02 March 2022
The Board of Wockhardt will meet on 03 March 2022 to consider and approve the terms and conditions of the rights issue and other related matters
The Board of Vipul Organics at its meeting held on 28 February 2022 has approved issuance of bonus equity shares in ratio of 14 The Board also approved increase in authorised share capital from Rs 1050 crore to Rs 1350 crore The Board also allotted 334000 equity shares on conversion of warrants
Page Industries announced the resignation of Sunder Genomal as Managing Director of the company with effect from 31 May 2022 He will continue as Non-Executive Director
Ducon Infratechnologies has announced a bonus issue of 1 share for ever 10 shares The Board of the company also approved an increase in authorised share capital from Rs 25 crore to Rs 30 crore
Tanla Platforms announced an exclusive partnership with Truecaller at MWC22 Barcelona Truecaller Business Messaging will be exclusively powered by Tanlas Wisely CPaaS platform Wisely is one of the worlds largest blockchain-enabled CPaaS platforms secured by e2e cryptographic encryption
Infibeam Avenues announced that Hiren Padhya Chief Financial Officer and Key Managerial Personnel of the Company has resigned from the position
Solara Active Pharma Sciences announced that Rajender Juwadi Rao will assume charge as Managing Director Chief Executive Officer with effect from 01 March 2022 He replaces Bharath R Sesha who resigned as Managing Director Chief Executive Officer with effect from 28 February March 2022
The Board of Easy Trip Planners will meet on 03 March 2022 to consider and approve the allotment of bonus equity shares
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
